Dr Richard Booton PhD MRCP

European Respiratory Society

International Association for the Study of Lung Cancer

British Thoracic Oncology Group

American College of Chest Physicians

American Association for Bronchology and Interventional Pulmonology
 

Principal Investigator (Manchester): LungSEARCH (Cancer Research UK)

Principal Investigator: Incidence, Prevalence, and Biology of Progressive Preneoplastic Bronchial Dysplasia in Two Distinct, Potential Screening Cohorts, of Patients At High Risk for Lung Cancer (The Charitable Moulton Foundation), including The Wythenshawe Respiratory Health Study (F Nordin, A Povey) and an Exon Array Analysis of Progressive Bronchial Dysplasia (L Brown/ G Landberg)

Principal Investigator (UHSM): Molecular mechanisms underlying chemotherapy resistance, therapeutic escape, efficacy and toxicity (European Union FP6 Chemores)

Principal Investigator: A Proteomic Exploration of Early Stage Lung Cancer Using Differential Analysis of Pulmonary Venous & Arterial Blood

Co-Investigator: Long non-coding RNAs and the development of lung cancer (M Lindsay/ S Griffith Jones)

Principal Investigator:  An Integrative Genomic Exploration of Preinvasive and Recurrent NSCLC

Provision and Supervision of The Foundation Programme (>70 newly qualified doctors) at the University Hospital of South Manchester (UHSM), with particular emphasis on Academic Foundation Trainees

Central/South Zonal Core Medical Training Lead for Respiratory Medicine

Respiratory Medicine Teaching Programme at UHSM

Medical Student Teaching (Out-patients/ Bronchoscopy)

After graduation from the University of Leeds in 1992 (MB ChB), Dr Booton completed general professional training in West Yorkshire (Bradford & Airedale) and Specialist Respiratory/ general Internal Medicine Training in the North West, becoming a Member of the Royal College of Physicians in 1998. He developed a sub-speciality interest in Thoracic Malignancy, working extensively at the North West Lung Centre, The Christie Hospital and The Paterson Institute for Cancer Research, Manchester and successfully completed a thoracic oncology fellowship (Supervisor: Prof N Thatcher) and a PhD thesis on the pharmacogenomics of lung cancer in 2006.

Dr Booton is a founding member of the British Thoracic Oncology Group and currently serves on the Steering Committee. He also serves on the locoregional disease sub-committee of the NCRI Lung Cancer Group. Locally, Dr Booton has played a leading role in the development of the Manchester Cancer Research Centre lung cancer strategy and the development of lung cancer services at the regional thoracic centre, University Hospital of South Manchester. He sits on the MCRC Biobank Board.

Dr Booton's is a Clinical Senior Lecturer & Honorary Consultant Respiratory Physician in the School of Translational Medicine at The University of Manchester focussing on the development of a new thoracic oncology research group and portfolio in the early detection of thoracic malignancy and leads on two national portfolio studies, employs 3 research fellows, and 2 research nurses and an NIHR Clinical Lecturer. He has active collaborations with The Wolfson Molecular Imaging Centre (Prof Whetton), The University of Manchester (Dr Lindsay/ Dr Griffiths Jones/ Prof Radford/ Dr Linton/ Dr Blackhall) and AstraZeneca Pharmaceuticals (Dr D Blowers/ Prof A Hughes)/ Allegro Diagnostics (Boston, USA). To date grant income approaches £1M. 

Bachelor of Medicine, Bachelor of Surgery - University of Leeds 1992

Member of the Royal College of Physicians, London, UK 1998

Doctor of Philosophy PhD - University of Manchester 2006

Certificate of Completion Specialist Training (Respiratory & General Internal Medicine) 2007

Professor Stephen Spiro, University College London

Dr Mark Lindsay, The University of Manchester

Dr Sam Griffiths-Jones, The university of Manchester

Dr Fiona Blackhall, The Christie Hospital

Professor Goran Landberg, The University of Manchester

Professor Tony Whetton, University of Manchester

Professor John Radford, The Christie Hospital

AstaZeneca Pharmaceuticals

Allegro Diagnostics

Manchester Cancer Research Centre